A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Hasan, B. et al. (35 more authors) (2020) A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial. Journal of Thoracic Oncology. ISSN 1556-0864

Abstract

Metadata

Authors/Creators:
  • Peters, S.
  • Danson, S. ORCID logo https://orcid.org/0000-0002-3593-2890
  • Hasan, B.
  • Dafni, U.
  • Reinmuth, N.
  • Majem, M.
  • Tournoy, K.G.
  • Mark, M.T.
  • Pless, M.
  • Cobo, M.
  • Rodriguez-Abreu, D.
  • Falchero, L.
  • Moran, T.
  • Ortega Granados, A.L.
  • Monnet, I.
  • Mohorcic, K.
  • Sureda, B.M.
  • Betticher, D.
  • Demedts, I.
  • Macias, J.A.
  • Cuffe, S.
  • Luciani, A.
  • Sanchez, J.G.
  • Curioni-Fontecedro, A.
  • Gautschi, O.
  • Price, G.
  • Coate, L.
  • von Moos, R.
  • Zielinski, C.
  • Provencio, M.
  • Menis, J.
  • Ruepp, B.
  • Pochesci, A.
  • Roschitzki-Voser, H.
  • Besse, B.
  • Rabaglio, M.
  • O’Brien, M.E.R.
  • Stahel, R.A.
Copyright, Publisher and Additional Information: © 2020 International Association for the Study of Lung Cancer. This is an author produced version of a paper subsequently published in Journal of Thoracic Oncology (JTO). Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: NSCLC; RANK; RANKL; Denosumab; Bone metastases
Dates:
  • Accepted: 7 June 2020
  • Published (online): 18 June 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
European Organisation for Research and Treatment of Cancer08111
Depositing User: Symplectic Sheffield
Date Deposited: 30 Jul 2020 10:40
Last Modified: 05 Aug 2020 12:37
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jtho.2020.06.011
Related URLs:

Download

Accepted Version


Embargoed until: 18 June 2021

Filename: JTO-D-20-00668R1_SPLENDOUR_revised_manuscript_clean.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

file not available

Share / Export

Statistics